Screener
Alamar Biosciences ALMR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $5,635 | $5,872 |
| Accrued and other current liabilities | 16,814 | 15,759 |
| Short-term operating lease liabilities | 1,599 | 2,099 |
| Total current liabilities | 24,048 | 23,730 |
| Long-term operating lease liabilities | 28,979 | 29,564 |
| Warrant liabilities | 331 | 247 |
| Term debt | 9,877 | 9,810 |
| Convertible note | 65,094 | — |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's total current liabilities?
- Alamar Biosciences (ALMR) reported total current liabilities of $24.05M in Q1 2026.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Alamar Biosciences's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude